Trendlines Group
Trendlines Group is a publicly listed Israel- and Singapore-based incubator that invests in and supports early-stage agrifood and medtech startups, generating returns through fund management fees, carried interest, and equity exits from its hands-on portfolio.
- Company typePublic
- Founded2007
- HeadquartersMisgav, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Trendlines Group does
Trendlines Group is a publicly listed (SGX: 42T; OTCQX: TRNLY) startup incubator and venture capital firm headquartered in Misgav, Israel with a regional office in Singapore. The company invests in seed and early-stage companies developing proprietary technologies in two verticals: agrifood (e.g., Phytolon's fermentation-based natural food colors, AgroScout's AI crop monitoring, Celleste Bio's cell-cultured cocoa, IBI Ag's bioinsecticides) and medtech (e.g., Escala Medical's incision-free POP repair, Vensica's needle-free ultrasound drug delivery, Limaca's Precision-GI biopsy device, ElastiMed's electroactive polymer wearables, ZygoFix's lumbar facet fixation, Ceretrieve's stroke aspiration catheter).
The business model combines fund management (Trendlines Agrifood Fund, formerly with Temasek and Librae Holdings as $22M anchor LPs; Bayer Trendlines Ag Innovation Fund until its December 2024 dissolution; the newly partnered Proterra Trendlines Fund) with hands-on equity investing across the portfolio lifecycle. Trendlines takes an operating role in technology development, regulatory navigation, business building and commercialization, and monetizes through management fees, carried interest (60% retained in the Proterra vehicle) and equity returns at exit, illustrated by the ApiFix sale to OrthoPediatrics (2020) and OrthoSpin sale to Johnson & Johnson (2021).
Following a strategic pivot in 2024–2025 that included leadership changes, the dissolution of the Bayer vehicle, disposal of business units, technical merger of a subsidiary, and a ~60% reduction in operating costs, Trendlines returned to profitability in FY2025. The company continues to drive portfolio company momentum, with Phytolon securing FDA approval for Beetroot Red and a $23.6M Series B in 2026, Vensica receiving FDA IND clearance for a Phase 2 trial, and ElastiMed entering the US market via a distribution partnership.
Trendlines Group firmographics
Firmographics- Name
- Trendlines Group
- Legal name
- The Trendlines Group Ltd.
- Website
- https://trendlines.com
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Trendlines Group is a publicly listed Israel- and Singapore-based incubator that invests in and supports early-stage agrifood and medtech startups, generating returns through fund management fees, carried interest, and equity exits from its hands-on portfolio.
- Ownership category
- akta.pro rank
Trendlines Group industry classification
Industry- Product category
- Venture Capital Incubation
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Transition / Engagement & Stewardship Funds (FSANAJAO)
- akta.pro secondary industry
- Sustainability & ESG Consulting (BPAHACAK)
Keywords
Where Trendlines Group is headquartered
LocationHeadquarters
- HQ city
- Misgav
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Trendlines Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Portfolio Investment Returns: Trendlines generates returns through equity investments in portfolio companies. The company returns to profitability in FY2025 after strategic pivot, supported by gains from portfolio companies and strategic exits.
- Fund Management Fees: The company manages venture funds including the Trendlines Agrifood Fund, receiving management fees and carried interest (Proterra receives 40% of carried interests while Trendlines retains 60%).
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Trendlines Group product offering
Product offeringCore offering
Trendlines Group is a publicly listed (SGX: 42T; OTCQX: TRNLY) startup incubator and venture capital investor focused on innovation-based medical and agrifood technologies. The company takes a hands-on approach, investing in seed-stage companies and providing operational support from technology development through business building. It manages specialized funds including the Trendlines Agrifood Fund (now Proterra Trendlines Fund) and previously the Bayer Trendlines Ag Innovation Fund.
Product overview
Trendlines Group is a Singapore-listed startup incubator and investor focused on agrifood and medtech innovations. The company does not offer a single unified product but rather invests in and supports portfolio companies developing distinct technologies. In agrifood, key portfolio companies include Phytolon (natural food colors via fermentation), AgroScout (AI crop monitoring), Celleste Bio (cell-cultured cocoa), IBI Ag (bioinsecticides), and others. In medtech, portfolio includes Escala Medical (pelvic organ prolapse repair device), ElastiMed (wearable compression devices), Vensica Medical (needle-free drug delivery), Limaca Medical (endoscopic biopsy devices), and others spanning urology, orthopedics, aesthetics, and surgical applications.
Differentiator
Problem solved
Functional benefit
Brands
- Trendlines Agrifood Fund: Agrifood-focused investment fund originally launched in 2019 with anchor commitments from Temasek and Librae Holdings, renamed Proterra Trendlines Fund under new management by Proterra Investment Advisors.
- Bayer Trendlines Ag Innovation Fund
- Trendlines Innovation Labs
Products and services
- Trendlines Agrifood Fund (Proterra Trendlines Fund)
Quantifiable outcome
- Returned to profitability in FY2025 after 60% operating cost reduction
- +2 more outcomes
Companies that use Trendlines Group
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Trendlines Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Trendlines Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and flagship.
- LaboriecoreLaborie, a prominent urology medical device company, is a strategic partner and investor in Vensica Medical supporting Phase 2 trials.
- HekaBiocoreHekaBio K.K. is the distribution partner for Limaca Medical's Precision-GI Endoscopic Biopsy Device in Japan, providing full operational capability and ensuring PMDA regulatory compliance.
- Merz TherapeuticsflagshipVensica Medical (Trendlines portfolio company) has a strategic partnership with Merz Therapeutics, licensing Xeomin for needle-free urological applications with exclusive rights in several indications.
- DSM-FirmenichflagshipPhytolon (Trendlines portfolio company) entered a commercial agreement with DSM for distribution of its natural food colors produced through baker's yeast fermentation.
- Ginkgo BioworkscorePhytolon has an R&D collaboration agreement with Ginkgo Bioworks for production of natural food colors. Ginkgo provides in-kind investment in the form of Foundry services.
- Genesis BiologicscoreGenesis Biologics has a partnership agreement with Arcuro Medical for sales, marketing, and distribution of the SuperBall Meniscus Repair System in the United States.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
Trendlines Group competitors and assessment
Company assessmentDirect peers
- OurCrowd: Israel-based venture investing platform deploying capital into early-stage startups across sectors including agrifood and medical technologies. Operates a comparable model of curating and supporting portfolio companies from seed through growth, often co-investing with strategic corporates.
- Pontifax: Israel-based life-sciences venture capital firm investing in early- and growth-stage medtech and biotech companies. Directly comparable in geography and the Israeli medtech incubation thesis that underpins Trendlines' portfolio.
- AgFunder: Venture capital firm and platform focused exclusively on agrifood technology investments. Directly comparable to Trendlines' Agrifood Fund thesis around sustainable food, agtech, and food-tech commercialization.
- Cultivian Sandbox Ventures: US venture fund focused on agrifood technology investments spanning crop production, animal health, and food innovation. Closely comparable to the Trendlines Agrifood Fund in sector mandate and stage focus.
- Rainbow Medical: Israel-based medical device incubator that seeds, develops and spins out innovative healthcare technologies. Directly comparable in the Israeli medtech incubation model and operational hands-on support.
- Integra Holdings: Israeli holding company investing in early-stage life sciences and medtech ventures, supporting them from inception through commercialization. Comparable to Trendlines' Israeli medtech incubation and value-building role.
Broad incumbents
- Flagship Pioneering: Larger US-based innovation platform that both creates and funds breakthrough science companies across healthcare, sustainability and agriculture. Comparable operating model (in-house origination plus investment) but at materially greater scale and a broader sector mandate.
- ARCH Venture Partners: Established US deep-tech and life-sciences venture firm investing from seed through later stages. Comparable in deploying early-stage capital into science-based medtech and agritech platforms, though at substantially larger fund sizes.
Others
- Temasek Holdings: Singapore-headquartered sovereign investor and anchor LP in the Trendlines Agrifood Fund. Comparable as a large-scale, sustainability-aware investor in agrifood and healthcare innovation, but as an LP rather than a peer manager.
- Bayer CropScience (Leaps by Bayer): Strategic corporate venture arm previously partnering with Trendlines via the Bayer Trendlines Ag Innovation Fund. Comparable as a large agritech investor and LP/corporate partner co-investing in early-stage agricultural technologies alongside funds like Trendlines'.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Trendlines Group social profiles
Digital presenceTrendlines Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trendlines Group leadership team
Management profileNumber of profiles
Profiles4 records
Trendlines Group funding detail
Funding detailFunding overview
Funding rounds12 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trendlines Group M&A and investment
M&A and investmentM&A
Investments66 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trendlines Group
What does Trendlines Group do?
Trendlines Group is a publicly listed (SGX: 42T; OTCQX: TRNLY) startup incubator and venture capital investor focused on innovation-based medical and agrifood technologies. The company takes a hands-on approach, investing in seed-stage companies and providing operational support from technology development through business building. It manages specialized funds including the Trendlines Agrifood Fund (now Proterra Trendlines Fund) and previously the Bayer Trendlines Ag Innovation Fund.
Is Trendlines Group a public or private company?
Trendlines Group is a public company. It is classified as public and is currently operating.
When was Trendlines Group founded?
Trendlines Group was founded in 2007. It employs 11 to 50 people.
Where is Trendlines Group based?
Trendlines Group is headquartered in Misgav, Israel, in the Middle East region.
How does Trendlines Group make money?
Two revenue lines are on record. Portfolio Investment Returns are the primary driver. The others are fund Management Fees.
Who are Trendlines Group's main competitors?
Direct peers on record are OurCrowd, Pontifax, AgFunder, Cultivian Sandbox Ventures, Rainbow Medical and Integra Holdings. Broad incumbents are Flagship Pioneering and ARCH Venture Partners. Others are Temasek Holdings and Bayer CropScience (Leaps by Bayer).
Does Trendlines Group have an API?
No public API is recorded for Trendlines Group.
What industry is Trendlines Group in?
Trendlines Group's product category is Venture Capital Incubation. Its primary akta.pro industry code is FSANAJAO, Transition / Engagement & Stewardship Funds, with a secondary code of BPAHACAK, Sustainability & ESG Consulting. Its NAICS code is 523940 and its SIC code is 6282.